|
Dear Colleagues,
Welcome to our March 2012 issue of Science Speaks!.
This month's issue features Brazil's leading role in the planting of biotech crops, our contribution in a report analyzing Argentina's promising pharmaceutical market, recommended best practices for drug trademark naming in 2012, and more.
Visit our website at www.languageconnections.com for more information about our services or to read more of our life science articles.
Enjoy!
|
|
Brazil Expected to Take the Lead in Biotech Crops
|
|
 Global genetically modified crop plantings rose 8.1 % last year as Brazilian farmers grew more pesticide-resistant soybeans, and the U.S. raised more biotech corn and cotton.
Brazil is expected to take the lead as the country with the most biotech crops. It is the first developing country to produce a genetically engineered crop in a public institution.
Read more...
|
|
Argentina's Pharma Market: GBI Executive Summary Report
|
|
Argentina's pharmaceutical market is expected to be the third most important market in Latin America.
Moreover, despite the role of generics and dominance by local players, foreign investment continues to be favorable.
Look for our contribution in the GBI Research Pharma Executive Summary Report (April 2012) which discusses the promising outlook of Argentina's Pharmaceutical Market. 
Read more...
|
|
We are very pleased to share our newsletter with you. If you have any inquiries, comments, or suggestions, please contact us or visit our website at www.languageconnections.com!
Sincerely,
Leo Galperin, President
Language Connections
Boston, MA
Tel. 617-731-3510
|
